Northwestern Mutual Wealth Management
NAVB

Northwestern Mutual Wealth Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-110
Closed -$10 – 3618
2023
Q2 		$10 Buy
+110
New +$18 ﹤0.01% 3313
2022
Q1 		– Sell
-237
Closed – – 3565
2021
Q4 		$0 Buy
+237
New +$334 ﹤0.01% 3466

Other funds holding NAVB

Allred Capital Management
Allred Capital Management Dallas, Texas $305M AUM 26.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Level Four Advisory Services
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Northwestern Mutual Wealth Management's NAVB Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q3 2023, closing a stake of 110 shares — an estimated $10 sold.

Northwestern Mutual Wealth Management first reported a position in NAVB in Q4 2021 and held it in 2 quarters. The position peaked at $10 in Q2 2023. 24 funds tracked by Wall St. Rank hold NAVB as of Q3 2023.

  • Northwestern Mutual Wealth Management reported no remaining Navidea Biopharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 110 Navidea Biopharmaceuticals Inc. shares in Q3 2023, an estimated $10.
  • Northwestern Mutual Wealth Management first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2021 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Navidea Biopharmaceuticals Inc. position peaked at $10 in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.